In a landmark decision that has sent shockwaves through the global pharmaceutical industry, Canada has officially become...
Chemotherapy and Targeted Therapy
In a move that signals a seismic shift in the architecture of pharmaceutical research and development, Bristol...
WASHINGTON, D.C. — In a development that signals a profound shift in the regulatory landscape of the...
In a transformative move for the neurology sector, privately held biotech firm Mentari Therapeutics has announced a...
By Ben Fidler | Published May 18, 2026 Regeneron Pharmaceuticals, long considered a gold standard in the...
In a high-stakes pivot that signals the maturation of AI-driven biotechnology, the startup Cellular Intelligence (formerly known...
By Jonathan Gardner Published May 18, 2026 In a high-stakes move to secure its long-term market dominance,...
In the fast-moving world of telehealth, few companies have captured the public imagination—or the ire of regulators—quite...
In the heart of the Boston-Cambridge life sciences ecosystem—a global nexus for pharmaceutical innovation—Sai Life Sciences recently...
The global pharmaceutical landscape has undergone a seismic shift. For years, Merck’s oncology powerhouse, Keytruda (pembrolizumab), stood...
